Hedge Fund - Kynam Capital
Biocryst Pharmaceuticals Inc (BCRX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $66,963,923 | 5.63% | 8,928,523 | $8.07 |
2 | 2024 - Q4 (2024-12-31) | $68,321,967 | 4.03% | 9,085,368 | $7.59 |
3 | 2024 - Q3 (2024-09-30) | $69,048,797 | 5.29% | 9,085,368 | $7.60 |
4 | 2024 - Q2 (2024-06-30) | $54,549,068 | 4.2% | 8,826,710 | $5.52 |
5 | 2024 - Q1 (2024-03-31) | $33,159,654 | 3.47% | 6,527,491 | $5.62 |
6 | 2023 - Q4 (2023-12-31) | $27,554,000 | 3.05% | 4,600,000 | $5.79 |
7 | 2023 - Q3 (2023-09-30) | $22,183,006 | 3.62% | 3,133,193 | $7.18 |
8 | 2023 - Q2 (2023-06-30) | $20,051,307 | 2.75% | 2,848,197 | $8.02 |
9 | 2023 - Q1 (2023-03-31) | $8,340,000 | 1.07% | 1,000,000 | $9.63 |
10 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $12.47 |
11 | 2022 - Q3 (2022-09-30) | $5,482,000 | 1.15% | 435,117 | $12.87 |
12 | 2022 - Q2 (2022-06-30) | $9,909,000 | 2.53% | 936,563 | $10.32 |
The displayed share prices are average quarterly stock market prices.